Role of leukemia inhibitory factor in nasopharyngeal carcinogenesis

Shu Chen Liu, Yu Sun Chang

研究成果: 雜誌貢獻回顧評介論文同行評審

10 引文 斯高帕斯(Scopus)

摘要

Although Epstein-Barr virus-associated nasopharyngeal carcinoma (NPC) is a highly radiosensitive cancer, approximately 20% of patients with NPC develop local recurrence after radiation therapy. Multiple proinflammatory cytokines are thought to protect NPC tumor cells from immune surveillance and therapeutic interventions. The cytokine leukemia inhibitory factor (LIF) is a critical component of the NPC microenvironment. LIF influences tumor growth and survival, and is therefore considered a potential therapeutic target and/or prognostic predictor for NPC. High LIF levels have been detected in the circulating blood of patients with recurrent NPC and NPC tumor cells. This review discusses the molecular mechanisms that link LIF to NPC tumor progression and radioresistance.

原文???core.languages.en_GB???
文章編號e29900
期刊Molecular and Cellular Oncology
1
發行號1
DOIs
出版狀態已出版 - 1 1月 2014

指紋

深入研究「Role of leukemia inhibitory factor in nasopharyngeal carcinogenesis」主題。共同形成了獨特的指紋。

引用此